NewGenIvf director Cheung Kong Yiu is 10% owner

The filing was made late, citing notarization and EDGAR credential delays for the newly appointed director, Cheung Kong Yiu, effective June 8, 2026.

Rhea-AI Filing Summary

NewGenIvf Group Ltd (NIVF) reports the initial beneficial ownership status of Cheung Kong Yiu on a Form 3 as a director and ten percent owner. The company explains that this Form 3 was filed late due to administrative and logistical delays in obtaining remote/foreign notarization and processing EDGAR access credentials (Form ID) for the newly appointed reporting person, who became a director on June 8, 2026. No specific holdings or transactions are detailed in the data provided.

Key Figures

Buy transactions reported: 0 transactions Sell transactions reported: 0 transactions Net buy/sell shares: 0 shares

3 metrics

Buy transactions reported 0 transactions Transaction summary on the Form 3 snapshot

Sell transactions reported 0 transactions Transaction summary on the Form 3 snapshot

Net buy/sell shares 0 shares Net shares in the transaction summary on the Form 3 snapshot

Key Terms

ten percent owner, remote/foreign notarization, EDGAR access credentials, Form ID

4 terms

ten percent owner regulatory

"The Reporting Person was identified as a Director and ten percent owner"

remote/foreign notarization regulatory

"delays within the Company in securing the necessary remote/foreign notarization"

EDGAR access credentials regulatory

"processing the initial EDGAR access credentials (Form ID)"

Form ID regulatory

"processing the initial EDGAR access credentials (Form ID)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 3 disclose about NewGenIvf Group Ltd (NIVF)?

It reports the initial beneficial ownership status of Cheung Kong Yiu as a director and ten percent owner of NewGenIvf Group Ltd. The data snapshot provided does not list any specific holdings or transactions.

Who is the reporting person in this NewGenIvf Group Ltd (NIVF) Form 3?

The reporting person is Cheung Kong Yiu, identified as both a director and a ten percent owner of NewGenIvf Group Ltd. This establishes him as an insider subject to SEC reporting requirements.

When was Cheung Kong Yiu appointed a director of NIVF?

Cheung Kong Yiu was appointed as a director of NewGenIvf Group Ltd on June 8, 2026, according to the remarks section accompanying the Form 3.

Why was the NewGenIvf Group Ltd (NIVF) Form 3 filed late?

The company states the Form 3 was filed late due to administrative and logistical delays in securing the required remote/foreign notarization and processing the initial EDGAR access credentials (Form ID) for the newly appointed reporting person.

Does this NIVF Form 3 report any insider transactions or share holdings?

No insider transactions are listed, and the summary data shows zero reported transactions and no holding entries in the snapshot provided. The Form 3 primarily identifies status as director and ten percent owner.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 08:01 AM EDT Accepted by SEC EDGAR 09/02/2026 - 08:00 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cheung Kong Yiu

(Last) (First) (Middle)

1403, INTERCONTINENTAL RESIDENCES

MARASI DRIVE, BUSINESS BAY DUBAI

(Street)

DUBAI 00000

(City) (State) (Zip)

UNITED ARAB EMIRATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/08/2026

3. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 is being filed late due to administrative and logistical delays within the Company in securing the necessary remote/foreign notarization and processing the initial EDGAR access credentials (Form ID) for the newly appointed Reporting Person. The Reporting Person was appointed as a Director on June 8, 2026.

No securities are beneficially owned.

	/s/ Cheung Kong Yiu	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)